4-Methyl-2-pyrimidinecarbonitrile

Catalog No. :
ACWIDN087
CAS No. :
77768-02-6
Molecular Formula :
C6H5N3
Molecular Weight :
119.13

IUPAC Name:4-methylpyrimidine-2-carbonitrile

4-Methyl-2-pyrimidinecarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$52.00Login to see priceIn stockInquiry
250mg98%$69.00Login to see priceIn stockIn stock
1g98%$161.00Login to see priceIn stockIn stock
5g98%$502.00Login to see priceIn stockIn stock
25g98%$2435.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-2-pyrimidinecarbonitrile
IUPAC Name4-methylpyrimidine-2-carbonitrile
MDL No.MFCD13190572
Molecular FormulaC6H5N3
Molecular Weight119.13
SMILESCC1=CC=NC(=N1)C#N
InChI KeyXXQWGLMZNGIYQY-UHFFFAOYSA-N
Synonym4-Methylpyrimidine-2-carbonitrile;4-Methyl-2-pyriMidinecarbonitrile;2-Pyrimidinecarbonitrile, 4-methyl- (9CI);2-Cyano-4-methylpyrimidine;2-Pyrimidinecarbonitrile, 4-methyl- (9CI) ISO 9001:2015 REACH;2-Pyrimidinecarbonitrile, 4-methyl-
CAS No.77768-02-6
PubChem CID12684324

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H317
Precautionary Statement(s)
P280-P301+P310

Synthetic Route by SureRoute

1. ACWIDN087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSONA159 route compound structure diagram
    ACSONA15913036-57-2 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACWIDN087 route product structure diagram
    ACWIDN08777768-02-6 In Stock
Inquiry

2. ACWIDN087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSONA159 route compound structure diagram
    ACSONA15913036-57-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWIDN087 route product structure diagram
    ACWIDN08777768-02-6 In Stock
Inquiry

Comments (0)